Vince Shier and Ryan Smith, who recently joined Brown Rudnick, say their new firm offers a strong platform to provide strategic advice
Hiroshi Sheraton will join the firm alongside a transactional specialist from Covington & Burling
Paul Johns, IP litigation head for Pearce IP in New Zealand, discusses how the firm is becoming a truly trans-Tasman outfit by onboarding dual-qualified lawyers
Covington & Burling lawyers explain how they convinced a judge to overturn a jury’s verdict that AstraZeneca should pay $107.5 million for patent infringement
A trio of life sciences experts who moved to Morrison Foerster from Desmarais praised their new firm’s ‘outstanding’ litigation work
Data from Managing IP+’s Talent Tracker shows that the IP ambitions of Asian full-service firms and a life sciences focus in the US have prompted lateral moves
Chad Landmon, who joins in Washington DC, hopes to expand the firm’s Hatch-Waxman practice
Alban Kang, who has joined Singapore-based Robinson after three decades at Bird & Bird ATMD, shares why he’s eyeing AI and patent cases
Lawyers say the opening of the Milan central division this month is likely to boost the so far 'modest' activity in Italy
Jeffrey Morton, formerly a life sciences leader at Procopio, said he was drawn to Haynes Boone’s desire to grow in the sector
Siegmund Gutman, former chair of the life sciences patent group at Proskauer, is among a group of 10 lawyers to join Mintz Levin
Foley Hoag, which has hired a former in-house counsel at a biotech company, is the latest firm to expand its life sciences capabilities
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement
-
Sponsored by Purplevine IPXiaojuan Yu of Purplevine IP Group discusses the medical device industry in China and considers why changes to the law are welcomed
-
Sponsored by FB RiceLee Miles of FB Rice discusses Australia’s patent box scheme which is set to introduce the agricultural and low emissions technology sectors
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners discuss an IP case that led to the discovery, and removal, of fake fire-resistant glass from hospitals in Turkey
-
Sponsored by Wanhuida Intellectual PropertyThe China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
Daphne Lainson discusses feeding cats at 4.30am and why Dolly Parton is an inspiration
Partners at Anderson Mori & Tomotsune say AI and the UPC are providing new business opportunities and reveal why flexibility is key to retaining talent
Procopio partner Jeremy Edwards explains how his team identified the best prior art when seeking to cancel a patent
Scott McKeown, who moved to Wolf Greenfield one year ago, says the change has helped him tap into life sciences work and advise more patent owners
Interviews; Exclusives
Interviews; Exclusives
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
Each week Managing IP speaks to a different IP practitioner about their life and career
Senior leaders at Orrick reveal why they expect more client interest in the life sciences sector and discuss the firm’s work on AI cases
Pravin Anand and Vaishali Mittal of Anand & Anand explain how they helped Swiss pharma company Vifor secure a landmark win against generic companies in India
Mike Renaud, head of the IP division at Mintz, explains his business strategy and how the firm justifies charging higher rates
Fatima Hassan, director of Health Justice Initiative, says IP office actions can yield major wins for patients and activists
-
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone